Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
16 Results for "
M2 Peptide
" in MedChemExpress (MCE) Product Catalog:
Products (16)
16 Results for "M2 Peptide" in MCE Product Catalog:
Cat. No.: HY-P10449
CAS No.: 3098205-40-1
Target:
Research Areas:
1
1 Cited Publications
Cat. No.: HY-P1376A
Target:
Research Areas:
Cat. No.: HY-P11107
CAS No.: 2375823-45-1
Target:
Research Areas:
Cat. No.: HY-172273A
Cat. No.: HY-169089
Target:
Research Areas:
Cat. No.: HY-172273
Cat. No.: HY-172273C
Cat. No.: HY-P1376
CAS No.: 143675-79-0
Target:
Research Areas:
Cat. No.: HY-169089A
Target:
Research Areas:
Cat. No.: HY-172273B
Cat. No.: HY-118522
CAS No.: 688737-95-3
TP-110 is a proteasome inhibitor. TP-110 specifically inhibits the protease-like activity of the 20S proteasome, but does not affect the trypsin-like or peptidyl-glutamyl peptide hydrolysis activity. TP-110 inhibits the NF-κB pathway, activates caspase-8, -9, and -3, and causes PARP cleavage, significantly reducing the levels of cIAP-1 and XIAP. TP-110 causes cell cycle arrest at the G2/M phase and promotes apoptosis of cancer cells. TP-110 can be used in cancer research of prostate cancer and multiple myeloma, etc .
Cat. No.: HY-W276819
CAS No.: 893772-67-3
Target:
Research Areas:
PLK1-IN-9 (Compound M2) is an inhibitor for polo-like kinase 1 (PLK1), that inhibits PLK proteins modified with peptides 1010pT, cdc25c and PBIP, with IC50s of 1.6, 0.8 and 1.4 μM, respectively. PLK1-IN-9 inhibits proliferations of cancer cells HeLa, HL60, SNU387/499, HepG2, exhibits cytotoxicity and induces apoptosis. PLK1-IN-9 inhibits tumor growth in HepG2 xenograft mouse model .
Cat. No.: HY-400684
Tubulysin A intermediate-1 is an intermediate in the synthesis of the cytotoxic peptide Tubulysin A (HY-15995). Tubulysin A (TubA) is an antibiotic, anti-microtubule toxins, and apoptosis inducer isolated from myxobacteria. Tubulysin A has anti-angiogenic, anti-microtubule, anti-mitotic, and anti-proliferative activities. Tubulysin A arrests cells in the G2/M phase, effectively inhibits tubulin polymerization, and induces depolymerization of detached microtubules. Tubulysin A acts as an ADC cytotoxin (ADC Cytotoxin) to synthesize ADC .
Cat. No.: HY-P11753A
Target:
Research Areas:
Cat. No.: HY-P11753
CAS No.: 1187540-64-2
Target:
Research Areas:
Cat. No.: HY-180989
Research Areas:
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
